Race-Specific Differences in Endothelial Function: Predisposition of African Americans to Vascular Diseases

Background—The prevalence of the endothelium-impaired function disorders, such as hypertension and diabetes mellitus, and the severity of their complications are considerably greater in blacks than whites. Evidence has accumulated that superoxide (O2−) production and its interaction with nitric oxide (NO), yielding the strong oxidant peroxynitrite (ONOO−), play central roles in vascular pathophysiology. We hypothesized that the differences in endothelial NO/O2−/ONOO− metabolism may highlight the potential predisposition to endothelial dysfunction and cardiovascular complications prevalent in blacks. Methods and Results—Highly sensitive tandem electrochemical NO/O2−/ONOO− nanosensors were positioned in single human umbilical vein endothelial cells (HUVECs) isolated from blacks and whites, and the kinetics of NO/O2−/ONOO− release were recorded in vitro. HUVECs were also analyzed by Western immunoblotting and enzyme activity assays for NAD(P)H-oxidase and endothelial NO synthase (eNOS). Compared with whites, HUVECs from blacks elicited reduced release of bioactive NO with an accompanying increase in the release of both O2− and ONOO−. The greater potency of NO production because of eNOS upregulation in HUVECs from blacks is associated with a decrease in the NO bioavailability. This is due to increased NO degradation by excess O2− produced primarily by 2 enzymatic sources: NAD(P)H-oxidase and uncoupled eNOS. Conclusions—Compared with whites, the steady-state NO/O2−/ONOO− balance in endothelial cells from blacks is kept closer to the redox states characteristic for the endothelium-impaired function disorders. This may explain the differences in racial predisposition to the endothelium dysfunction during ongoing vascular disturbances with the hallmark of enhanced NO inactivation within the endothelium by oxidative stress.

[1]  T. Malinski,et al.  Cerivastatin potentiates nitric oxide release and enos expression through inhibition of isoprenoids synthesis. , 2002, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[2]  A. Dominiczak,et al.  NAD(P)H Oxidase Inhibition Improves Endothelial Function in Rat and Human Blood Vessels , 2002, Hypertension.

[3]  U. Walter,et al.  Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling , 2002, Circulation research.

[4]  L. Dobrucki,et al.  Increased Nitric Oxide Bioavailability in Endothelial Cells Contributes to the Pleiotropic Effect of Cerivastatin , 2002, Circulation.

[5]  M. Stratford,et al.  Oxidation of tetrahydrobiopterin by biological radicals and scavenging of the trihydrobiopterin radical by ascorbate. , 2002, Free radical biology & medicine.

[6]  R. Cohen,et al.  S17834, a New Inhibitor of Cell Adhesion and Atherosclerosis That Targets NADPH Oxidase , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[7]  T. Lüscher,et al.  Enhanced Peroxynitrite Formation Is Associated with Vascular Aging , 2000, The Journal of experimental medicine.

[8]  Y. Xian,et al.  Amperometric ultramicrosensors for peroxynitrite detection and its application toward single myocardial cells. , 2000, Analytical chemistry.

[9]  K. Channon,et al.  Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. , 2000, Circulation research.

[10]  G. Kojda,et al.  Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. , 1999, Cardiovascular research.

[11]  R. Cannon,et al.  Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function. , 1999, Circulation.

[12]  T. Poulos,et al.  Crystal Structure of Constitutive Endothelial Nitric Oxide Synthase A Paradigm for Pterin Function Involving a Novel Metal Center , 1998, Cell.

[13]  E. Moilanen,et al.  Radical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine. , 1998, European journal of pharmacology.

[14]  E. Werner,et al.  Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. , 1998, The Journal of clinical investigation.

[15]  U. Losert,et al.  L-arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. , 1997, Circulation.

[16]  A. Scheeline,et al.  Amperometric sensors for simultaneous superoxide and hydrogen peroxide detection. , 1997, Analytical chemistry.

[17]  Detection The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[18]  R. Weinshilboum,et al.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.

[19]  S. Snyder,et al.  Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Moncada,et al.  Direct measurement of nitric oxide in human beings , 1995, The Lancet.

[21]  P Whelton,et al.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. , 1995, Hypertension.

[22]  T. Malinski,et al.  Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor , 1992, Nature.

[23]  T. Malinski,et al.  Conductive polymeric porphyrin films: application in the electrocatalytic oxidation of hydrazine , 1991 .

[24]  J. Fleiss,et al.  Some Statistical Methods Useful in Circulation Research , 1980, Circulation research.